Maria P. Ceballos

Rosario, S, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Lomitapide reduces viability and clonogenicity in hepatocellular carcinoma cells but enhances xenograft growth: The importance of the tumor microenvironment.

Lomitapide reduces viability and clonogenicity in hepatocellular carcinoma cells but enhances xenograft growth: The importance of the tumor microenvironment.

Journal: The Journal of pharmacology and experimental therapeutics

Published: January 12, 2026

Unraveling the Role of Leukotriene A4 Hydrolase in Hepatocellular Carcinoma: Implications for Targeted Therapy and Tumor Progression.

Unraveling the Role of Leukotriene A4 Hydrolase in Hepatocellular Carcinoma: Implications for Targeted Therapy and Tumor Progression.

Journal: Digestive diseases and sciences

Published: March 01, 2025

Role of the RNA binding protein IGF2BP1 in cancer multidrug resistance.

Role of the RNA binding protein IGF2BP1 in cancer multidrug resistance.

Journal: Biochemical pharmacology

Published: June 12, 2024

Extracellular Vesicles and Cancer Multidrug Resistance: Undesirable Intercellular Messengers?

Extracellular Vesicles and Cancer Multidrug Resistance: Undesirable Intercellular Messengers?

Journal: Life (Basel, Switzerland)

Published: June 21, 2023

Role of sirtuins in hepatocellular carcinoma progression and multidrug resistance: Mechanistical and pharmacological perspectives.

Role of sirtuins in hepatocellular carcinoma progression and multidrug resistance: Mechanistical and pharmacological perspectives.

Journal: Biochemical pharmacology

Published: February 13, 2023

Delta-tocotrienol enhances the anti-tumor effects of interferon alpha through reactive oxygen species and Erk/MAPK signaling pathways in hepatocellular carcinoma cells.

Delta-tocotrienol enhances the anti-tumor effects of interferon alpha through reactive oxygen species and Erk/MAPK signaling pathways in hepatocellular carcinoma cells.

Journal: Canadian journal of physiology and pharmacology

Published: December 21, 2021

The chemoprotective effects of IFN-α-2b on rat hepatocarcinogenesis are blocked by vitamin E supplementation.

The chemoprotective effects of IFN-α-2b on rat hepatocarcinogenesis are blocked by vitamin E supplementation.

Journal: The Journal of nutritional biochemistry

Published: December 24, 2020

Sirtuin 1 and 2 inhibitors enhance the inhibitory effect of sorafenib in hepatocellular carcinoma cells.

Sirtuin 1 and 2 inhibitors enhance the inhibitory effect of sorafenib in hepatocellular carcinoma cells.

Journal: European journal of pharmacology

Published: June 24, 2020

IFN-α-2b induces apoptosis by decreasing cellular cholesterol levels in rat preneoplastic hepatocytes.

IFN-α-2b induces apoptosis by decreasing cellular cholesterol levels in rat preneoplastic hepatocytes.

Journal: Cytokine

Published: March 27, 2020

Participation of 5-lipoxygenase and LTB4 in liver regeneration after partial hepatectomy.

Participation of 5-lipoxygenase and LTB4 in liver regeneration after partial hepatectomy.

Journal: Scientific reports

Published: July 03, 2019

IFN-α-2b treatment protects against diet-induced obesity and alleviates non-alcoholic fatty liver disease in mice.

IFN-α-2b treatment protects against diet-induced obesity and alleviates non-alcoholic fatty liver disease in mice.

Journal: Toxicology and applied pharmacology

Published: March 21, 2019

Vitamin K2 supplementation blocks the beneficial effects of IFN-α-2b administered on the early stages of liver cancer development in rats.

Vitamin K2 supplementation blocks the beneficial effects of IFN-α-2b administered on the early stages of liver cancer development in rats.

Journal: Nutrition (Burbank, Los Angeles County, Calif.)

Published: July 05, 2018

Showing 1-12 of 24

Last Updated: 09/26/2026